tradingkey.logo
tradingkey.logo
Suchen

Medifast Inc

MED
Zur Watchlist hinzufügen
11.010USD
-0.020-0.18%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
121.87MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Medifast Inc Unternehmen

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.

Medifast Inc Informationen

BörsenkürzelMED
Name des UnternehmensMedifast Inc
IPO-datumDec 30, 1993
CEOChard (Daniel R)
Anzahl der mitarbeiter504
WertpapierartOrdinary Share
GeschäftsjahresendeDec 30
Addresse100 International Drive, 18th Floor
StadtBALTIMORE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl21202
Telefon14105818042
Websitehttps://medifastinc.com/
BörsenkürzelMED
IPO-datumDec 30, 1993
CEOChard (Daniel R)

Führungskräfte von Medifast Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
242.04K
+31.85%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.53K
+47.62%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.40K
+35.00%
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Scott D. Schlackman
Mr. Scott D. Schlackman
Independent Director
Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--
Mr. Nicholas M. Johnson
Mr. Nicholas M. Johnson
Chief Field Operations Officer
Chief Field Operations Officer
--
--
Mr. Michael A. Hoer
Mr. Michael A. Hoer
Independent Director
Independent Director
--
--
Mr. Ming Xian
Mr. Ming Xian
Independent Director
Independent Director
--
--
Ms. Claudia C. Greninger
Ms. Claudia C. Greninger
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel R. (Dan) Chard
Mr. Daniel R. (Dan) Chard
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
242.04K
+31.85%
Ms. Andrea B. Thomas
Ms. Andrea B. Thomas
Independent Director
Independent Director
24.53K
+47.62%
Mr. Jason L. Groves, Esq., J.D.
Mr. Jason L. Groves, Esq., J.D.
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.40K
+35.00%
Mr. Jeffrey J. Brown
Mr. Jeffrey J. Brown
Lead Independent Director
Lead Independent Director
--
--
Mr. Scott D. Schlackman
Mr. Scott D. Schlackman
Independent Director
Independent Director
--
--
Mr. Anthony E. Tyree
Mr. Anthony E. Tyree
Chief Marketing Officer, Chief Business Operations
Chief Marketing Officer, Chief Business Operations
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Medifast Inc?

Die fünf größten Anteilseigner von Medifast Inc sind: Mr. Daniel R. (Dan) Chard

Wie viele Institutionen halten Anteile an Medifast Inc (MED)?

Mit Stand vom 2026Q1 halten 401 Institutionen Anteile an Medifast Inc, mit einem Gesamtmarktwert von etwa 9.25M, was 83.21% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -4364386.00 gestiegen.